[A successful case of living donor liver transplantation performed in 7 hours for sub acute fulminant hepatitis].

Yoko Zaitsu, Toru Ikegami, Toshirou Masuda, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Living donor liver transplantation (LDLT) is the ultimate cure for fulminant hepatitis. Successful outcomes rely on the precise evaluation of the reversibility of hepatic encephalopathy, and a swift execution of necessary examination of both the donor and the recipient. The case was a 63-years old woman, presented with fever and loss of appetite. She was hospitalized for acute hepatitis and treated at a nearby hospital. She was transferred to the tertiary hospital for the acute deterioration of her liver function on the 7th day after the emergence of the initial symptoms. On the 10th day, she showed Grade 2 encephalopathy and underwent plasma exchange. She was transported to our hospital for possible LDLT on the 11th day. CT scan on arrival showed severe atrophy of her liver and no definite brain edema despite acutely deteriorating encephalopathy (Grade 3). LDLT was launched after 7 hours from her transport. She was discharged from the intensive care unit on the 6th day and was discharged without severe complications on 42th day after the LDLT.

Original languageEnglish
Pages (from-to)145-149
Number of pages5
JournalFukuoka igaku zasshi = Hukuoka acta medica
Volume103
Issue number7
Publication statusPublished - Jul 2012

Fingerprint

Living Donors
Liver Transplantation
Hepatitis
Brain Diseases
Plasma Exchange
Hepatic Encephalopathy
Liver
Brain Edema
Appetite
Tertiary Care Centers
Atrophy
Intensive Care Units
Fever
Tissue Donors

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[A successful case of living donor liver transplantation performed in 7 hours for sub acute fulminant hepatitis]. / Zaitsu, Yoko; Ikegami, Toru; Masuda, Toshirou; Yoshizumi, Tomoharu; Shirabe, Ken; Maehara, Yoshihiko.

In: Fukuoka igaku zasshi = Hukuoka acta medica, Vol. 103, No. 7, 07.2012, p. 145-149.

Research output: Contribution to journalArticle

@article{e7941a306a3c452ab65a7f550cf7a872,
title = "[A successful case of living donor liver transplantation performed in 7 hours for sub acute fulminant hepatitis].",
abstract = "Living donor liver transplantation (LDLT) is the ultimate cure for fulminant hepatitis. Successful outcomes rely on the precise evaluation of the reversibility of hepatic encephalopathy, and a swift execution of necessary examination of both the donor and the recipient. The case was a 63-years old woman, presented with fever and loss of appetite. She was hospitalized for acute hepatitis and treated at a nearby hospital. She was transferred to the tertiary hospital for the acute deterioration of her liver function on the 7th day after the emergence of the initial symptoms. On the 10th day, she showed Grade 2 encephalopathy and underwent plasma exchange. She was transported to our hospital for possible LDLT on the 11th day. CT scan on arrival showed severe atrophy of her liver and no definite brain edema despite acutely deteriorating encephalopathy (Grade 3). LDLT was launched after 7 hours from her transport. She was discharged from the intensive care unit on the 6th day and was discharged without severe complications on 42th day after the LDLT.",
author = "Yoko Zaitsu and Toru Ikegami and Toshirou Masuda and Tomoharu Yoshizumi and Ken Shirabe and Yoshihiko Maehara",
year = "2012",
month = "7",
language = "English",
volume = "103",
pages = "145--149",
journal = "Fukuoka Acta Medica",
issn = "0016-254X",
publisher = "福岡医学会",
number = "7",

}

TY - JOUR

T1 - [A successful case of living donor liver transplantation performed in 7 hours for sub acute fulminant hepatitis].

AU - Zaitsu, Yoko

AU - Ikegami, Toru

AU - Masuda, Toshirou

AU - Yoshizumi, Tomoharu

AU - Shirabe, Ken

AU - Maehara, Yoshihiko

PY - 2012/7

Y1 - 2012/7

N2 - Living donor liver transplantation (LDLT) is the ultimate cure for fulminant hepatitis. Successful outcomes rely on the precise evaluation of the reversibility of hepatic encephalopathy, and a swift execution of necessary examination of both the donor and the recipient. The case was a 63-years old woman, presented with fever and loss of appetite. She was hospitalized for acute hepatitis and treated at a nearby hospital. She was transferred to the tertiary hospital for the acute deterioration of her liver function on the 7th day after the emergence of the initial symptoms. On the 10th day, she showed Grade 2 encephalopathy and underwent plasma exchange. She was transported to our hospital for possible LDLT on the 11th day. CT scan on arrival showed severe atrophy of her liver and no definite brain edema despite acutely deteriorating encephalopathy (Grade 3). LDLT was launched after 7 hours from her transport. She was discharged from the intensive care unit on the 6th day and was discharged without severe complications on 42th day after the LDLT.

AB - Living donor liver transplantation (LDLT) is the ultimate cure for fulminant hepatitis. Successful outcomes rely on the precise evaluation of the reversibility of hepatic encephalopathy, and a swift execution of necessary examination of both the donor and the recipient. The case was a 63-years old woman, presented with fever and loss of appetite. She was hospitalized for acute hepatitis and treated at a nearby hospital. She was transferred to the tertiary hospital for the acute deterioration of her liver function on the 7th day after the emergence of the initial symptoms. On the 10th day, she showed Grade 2 encephalopathy and underwent plasma exchange. She was transported to our hospital for possible LDLT on the 11th day. CT scan on arrival showed severe atrophy of her liver and no definite brain edema despite acutely deteriorating encephalopathy (Grade 3). LDLT was launched after 7 hours from her transport. She was discharged from the intensive care unit on the 6th day and was discharged without severe complications on 42th day after the LDLT.

UR - http://www.scopus.com/inward/record.url?scp=84868648107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868648107&partnerID=8YFLogxK

M3 - Article

C2 - 22978067

AN - SCOPUS:84868648107

VL - 103

SP - 145

EP - 149

JO - Fukuoka Acta Medica

JF - Fukuoka Acta Medica

SN - 0016-254X

IS - 7

ER -